Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2026-05-23 @ 5:12 AM
Study NCT ID:
NCT00270894
Status:
COMPLETED
Last Update Posted:
2012-03-20
First Post:
2005-12-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Sponsor:
Accelerated Community Oncology Research Network
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ACORN ALSSNBC0401
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |